{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:34Z","timestamp":1783525894557,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022768","name":"Maire Lisko Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022768","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With juvenile idiopathic arthritis (JIA), there are several protocols and practices used worldwide for the transition from paediatric to adult care. In this study, we examined the transferral rates and disease activity after transition, as well as the disease- and health-related outcomes. We also introduce the transition practices employed in the Nordic countries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study population comprised 408 participants with a disease onset from 1997 to 2000 who attended an 18-year follow-up visit in this population-based Nordic JIA cohort study. The patients were retrospectively divided into three subgroups: Patients transferred directly from paediatric care to adult rheumatology care, patients referred there later, and patients never transferred during the 18-year follow-up period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred and sixty-three (40%) JIA patients had been directly transferred to an adult clinic. The cumulative transition rate was 52%, but there were significant differences between the participating centres. Fifty patients had later been referred to an adult clinic. Among the 195 patients who had never been transferred, 39% were found to have disease activity at the study visit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study highlights the need to reconsider transition practices to avoid our undesirable finding of patients with disease activity in JIA, but no appropriate health care follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00742-2","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T18:02:22Z","timestamp":1664647342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8262-3636","authenticated-orcid":false,"given":"Katriina","family":"Mikola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katariina","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Dalen","family":"Arnstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillemor","family":"Berntson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fasth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Glerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels","family":"Herlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Nordal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Peltoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marite","family":"Rygg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Rypdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"issue":"6 Suppl 43","key":"742_CR1","first-page":"S105","volume":"24","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Clin Exp Rheumatol. 2007;24(6 Suppl 43):S105.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"742_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13075-019-1950-7","volume":"21","author":"G Giancane","year":"2019","unstructured":"Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, et al. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 2019;21(1):168.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"742_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/rheumatology\/ket256","volume":"52","author":"KL Vidqvist","year":"2013","unstructured":"Vidqvist KL, Malin M, Varjolahti-Lehtinen T, Korpela MM. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatol Oxf Engl. 2013;52(11):1999\u20132003.","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"742_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2017.05.003","volume":"47","author":"A Luque Ramos","year":"2017","unstructured":"Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2017;47(2):269\u201375.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"742_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jadohealth.2008.01.007","volume":"42","author":"JN Giedd","year":"2008","unstructured":"Giedd JN. The Teen Brain: Insights from Neuroimaging. J Adolesc Health. 2008;42(4):335\u201343.","journal-title":"J Adolesc Health"},{"issue":"10","key":"742_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-019-0855-4","volume":"21","author":"J McDonagh","year":"2019","unstructured":"McDonagh J, Farre A. Transitional Care in Rheumatology: a Review of the Literature from the Past 5 Years. Curr Rheumatol Rep. 2019;21(10):1\u201310.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"742_CR7","first-page":"1086","volume":"36","author":"F Conti","year":"2018","unstructured":"Conti F, Pontikaki I, D\u2019Andrea M, Ravelli A, De Benedetti F. Patients with juvenile idiopathic arthritis become adults: the role of transitional care. Clin Exp Rheumatol. 2018;36(6):1086\u201394.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"742_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/annrheumdis-2016-210112","volume":"76","author":"HE Foster","year":"2017","unstructured":"Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, et al. EULAR\/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76(4):639\u201346.","journal-title":"Ann Rheum Dis"},{"key":"742_CR9","doi-asserted-by":"crossref","unstructured":"Walter M, Kamphuis S, Van Pelt P, Vroed AD, Hazes J. Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases [Internet]. Figshare. 2018; Available from: https:\/\/search.datacite.org\/works\/10.6084\/m9.figshare.c.4188770.v1.","DOI":"10.1186\/s12969-018-0268-3"},{"issue":"6","key":"742_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jadohealth.2015.02.007","volume":"56","author":"JCMD Suris","year":"2015","unstructured":"Suris JCMD, Akre CMA. Key Elements for, and Indicators of, a Successful Transition: An International Delphi Study. J Adolesc Health. 2015;56(6):612\u20138.","journal-title":"J Adolesc Health"},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2022.2040117","volume":"11","author":"K Mikola","year":"2022","unstructured":"Mikola K, Rebane K, Glerup M, Kautiainen H, Relas H, Peltoniemi S, et al. Transition to adult care in Finnish adolescents with juvenile idiopathic arthritis. Scand J Rheumatol. 2022;11:1\u20135.","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"742_CR12","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30(10):2275\u201382.","journal-title":"J Rheumatol"},{"issue":"9","key":"742_CR13","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(9):2809\u201318.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"742_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/acr.23853","volume":"72","author":"M Glerup","year":"2020","unstructured":"Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, et al. Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based nordic juvenile idiopathic arthritis cohort. Arthritis Care Res. 2020;72(4):507\u201316.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"742_CR15","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"11","key":"742_CR16","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E. Childhood arthritis and rheumatology research alliance, pediatric rheumatology international trials organization, pediatric rheumatology collaborative study group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J Rheumatol"},{"issue":"7","key":"742_CR17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/art.21119","volume":"52","author":"S Viola","year":"2005","unstructured":"Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum. 2005;52(7):2092\u2013102.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"742_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137\u201345.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"742_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"MLL Prevoo","year":"1995","unstructured":"Prevoo MLL, Van\u2019T Hof MA, Kuper HH, Van Leeuwen MA, LBA VDP, PLCM VR. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"key":"742_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/0470846283","volume-title":"Quality of life. Assessment, analysis and interpretation","author":"P Fayers","year":"2000","unstructured":"Fayers P. Quality of life. Assessment, analysis and interpretation. 2nd ed: Wiley; 2000.","edition":"2"},{"key":"742_CR21","volume-title":"SF-36 physical and mentalhealth summary scales: A manual for users of version 1","author":"JE Ware","year":"2001","unstructured":"Ware JE, KM. SF-36 physical and mentalhealth summary scales: A manual for users of version 1. 2nd ed. Lincoln RI: QualityMetric Incorporated; 2001.","edition":"2"},{"issue":"Generic","key":"742_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3899\/jrheum.120602","volume":"40","author":"L Bertilsson","year":"2013","unstructured":"Bertilsson L, Andersson-G\u00e4re B, Fasth A, Petersson IF, Forsblad-D\u2019elia H. JCA 17-year followup Personal non-commercial use only. J Rheumatol. 2013;40(Generic):715.","journal-title":"J Rheumatol"},{"issue":"1","key":"742_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","volume":"75","author":"AM Selvaag","year":"2014","unstructured":"Selvaag AM, Aulie HA, Lilleby V, Flat\u00f8 B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2014;75(1):190.","journal-title":"Ann Rheum Dis"},{"key":"742_CR24","doi-asserted-by":"publisher","unstructured":"Rypdal V, Glerup M, Songstad NT, Bertelsen G, Christoffersen T, Arnstad ED, et al. Uveitis in Juvenile Idiopathic Arthritis. Ophthalmol Rochester Minn. 2020;(Journal Article). Available from. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.024.","DOI":"10.1016\/j.ophtha.2020.08.024"},{"issue":"6","key":"742_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/09273948.2013.815785","volume":"21","author":"AT Vitale","year":"2013","unstructured":"Vitale AT, Graham E, de Boer JH. Juvenile Idiopathic Arthritis-Associated Uveitis: Clinical Features and Complications, Risk Factors for Severe Course, and Visual Outcome. Ocul Immunol Inflamm. 2013;21(6):478\u201385.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"742_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1546-0096-8-20","volume":"8","author":"LN Moorthy","year":"2010","unstructured":"Moorthy LN, Peterson MG, Hassett AL, Lehman TJ. Burden of childhood-onset arthritis. Pediatr Rheumatol Online J. 2010;8(1):20.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"742_CR27","doi-asserted-by":"publisher","first-page":"F15","DOI":"10.1111\/j.1467-7687.2010.01014.x","volume":"13","author":"I Dumontheil","year":"2010","unstructured":"Dumontheil I, Houlton R, Christoff K, Blakemore SJ. Development of relational reasoning during adolescence. Dev Sci. 2010;13(6):F15\u201324.","journal-title":"Dev Sci"},{"key":"742_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1196\/annals.1440.010","volume":"1124","author":"BJ Casey","year":"2008","unstructured":"Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. 2008;1124:111\u201326.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"742_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neubiorev.2009.12.007","volume":"34","author":"D Wahlstrom","year":"2010","unstructured":"Wahlstrom D, White T, Luciana M. Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav Rev. 2010;34(5):631\u201348.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"742_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1472-6882-14-124","volume":"14","author":"P Nousiainen","year":"2014","unstructured":"Nousiainen P, Merras-Salmio L, Aalto K, Kolho KL. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis. BMC Complement Altern Med. 2014;14(1):124.","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"742_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1756-185X.13091","volume":"20","author":"M Lahiri","year":"2017","unstructured":"Lahiri M, Santosa A, Teoh LK, Clayton JA, Lim SY, Teng GG, et al. Use of complementary and alternative medicines is associated with delay to initiation of disease-modifying anti-rheumatic drug therapy in early inflammatory arthritis. Int J Rheum Dis. 2017;20(5):567\u201375.","journal-title":"Int J Rheum Dis"},{"key":"742_CR32","doi-asserted-by":"crossref","unstructured":"Kosola S, Relas H. Patients with psychiatric diagnoses have lower quality of life than other patients with juvenile rheumatic disease: a prospective study.\u00a0Rheumatol (Oxford). 2021;60(12):5560\u201366.","DOI":"10.1093\/rheumatology\/keab150"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00742-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T18:02:53Z","timestamp":1664647373000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00742-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00742-2","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants. The ethics committees and data protection authorities in the participating sites approved the study. The study was performed according to the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study did not receive any financial support or other benefits from commercial sources, and the authors have no financial interest, that can create a potential conflict of interest or the appearance of a conflict of interest. The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}